Perspectives & Insights

Novavax fuels our partnership approach by making smart R&D investments. We do this by generating and sharing data on the utility of Matrix-M® adjuvant, expanding the utility of our Matrix technology platform and creating new innovative vaccine candidates with our Matrix-M and nanoparticle technology platform to facilitate partnership discussions.

Below is a link to a video where our Executive Vice President and Head of Research & Development outlines how we prioritize and approach R&D to support partnership development that addresses global health needs.